Discovery of novel inhibition site centered on 114-bit tryptophan of Thioredoxin reductase 1 through computer-aided drug design
Thioredoxin reductase 1 (TrxR1) is an oxidoreductase playing the important role in the tumor cells. It is a new type of drug therapy target. Most of the existing TrxR1 inhibitors act directly covalently on the active sites. Herein, molecular docking-based virtual screening approach was used to scree...
Main Authors: | Haoyi Yang, Hengyu Wang, Jia Feng, Jianmin Liao, Yuanyuan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Arabian Journal of Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S187853522300103X |
Similar Items
-
Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells
by: Vanessa Pires, et al.
Published: (2022-06-01) -
The over expression of thioredoxin during malignancies
by: Shahaboddin Shabani, et al.
Published: (2014-10-01) -
The over expression of thioredoxin during malignancies
by: Shahaboddin Shabani, et al.
Published: (2014-09-01) -
Oxidized Forms of Ergothioneine Are Substrates for Mammalian Thioredoxin Reductase
by: Kaelyn A. Jenny, et al.
Published: (2022-01-01) -
Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery
by: Sara E. McCarty, et al.
Published: (2015-06-01)